Higher PPARGC1A activity triggers melanocyte inducing transcription factor expression, promoting a melanoma subtype [22–24]; PPARGC1A protects cancer cells from ROS-induced apoptosis, supporting cancer growth and progression in melanomas [23]. Here, PPARGC1A is linked to melanoma.